These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18376118)

  • 41. A misguided 'pill in the pocket' approach with flecainide leading to cardiac arrest.
    Kiblboeck D; Braeuer-Mocker M; Siostrzonek P; Reisinger J
    BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22927286
    [No Abstract]   [Full Text] [Related]  

  • 42. Flecainide-induced neuropathy.
    Malesker MA; Sojka SG; Fagan NL
    Ann Pharmacother; 2005 Sep; 39(9):1580. PubMed ID: 16076915
    [No Abstract]   [Full Text] [Related]  

  • 43. Flecainide-induced AV dyssynchrony and atrial latency progression in a patient with a dual-chamber pacemaker.
    Alston M; Chang D; Mitra R
    J Cardiovasc Electrophysiol; 2021 Jul; 32(7):2005-2010. PubMed ID: 34053127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Documentation of acute rise in ventricular capture thresholds associated with flecainide acetate.
    Fornieles-Pérez H; Montoya-García M; Levine PA; Sanz O
    Pacing Clin Electrophysiol; 2002 May; 25(5):871-2. PubMed ID: 12049386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia.
    Campbell JQ; Best TH; Eswaran H; Lowery CL
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):767-71. PubMed ID: 17018496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy.
    Forleo GB; Mantica M; De Luca L; Leo R; Santini L; Panigada S; De Sanctis V; Pappalardo A; Laurenzi F; Avella A; Casella M; Dello Russo A; Romeo F; Pelargonio G; Tondo C
    J Cardiovasc Electrophysiol; 2009 Jan; 20(1):22-8. PubMed ID: 18775050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ECGs in the ED.
    Tanel RE
    Pediatr Emerg Care; 2008 Nov; 24(11):803-4. PubMed ID: 19018229
    [No Abstract]   [Full Text] [Related]  

  • 48. Guidelines for the use of flecainide in patients with supraventricular arrhythmias.
    Smith W; Crozier I; McAlister H; O'Meeghan T; Stewart F
    N Z Med J; 2000 Oct; 113(1119):420-1. PubMed ID: 11127360
    [No Abstract]   [Full Text] [Related]  

  • 49. An irregular, extremely broad QRS complex rhythm.
    Wilgenhof A; Michiels V; Cosyns B
    Am J Emerg Med; 2019 Oct; 37(10):1989.e1-1989.e3. PubMed ID: 31362853
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of single-dose rosiglitazone in chronic ambulatory peritoneal dialysis patients.
    Aramwit P; Supasyndh O; Sriboonruang T
    J Clin Pharm Ther; 2008 Dec; 33(6):685-90. PubMed ID: 19138247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute reversible ataxo-myoclonic encephalopathy with flecainide therapy.
    Ghika J; Goy JJ; Naegeli C; Regli F
    Schweiz Arch Neurol Psychiatr (1985); 1994; 145(1):4-6. PubMed ID: 7526455
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cromolyn sodium: a potential therapy for uremic pruritus?
    Rosner MH
    Hemodial Int; 2006 Apr; 10(2):189-92. PubMed ID: 16623673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Metformin should not be used by patients with reduced renal function].
    Gudmundsdottir H; Brørs O; Os I
    Tidsskr Nor Laegeforen; 2008 Apr; 128(8):936-7. PubMed ID: 18431417
    [No Abstract]   [Full Text] [Related]  

  • 54. Cibenzoline intoxication: effect of combined hemoperfusion-hemodialysis on plasma clearance.
    Meeus R; Verpooten GA; De Paep R; Paelinck BP; Neels H; Cooreman S; De Doncker M; Jorens PG
    Clin Toxicol (Phila); 2008 Apr; 46(4):303-6. PubMed ID: 18363124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pneumoperitoneum--rare complication in end stage renal disease patient on automated peritoneal dialysis.
    Ionescu C; Ecobici M; Olaru D; Stănescu C; Lupescu I; Voiculescu M
    Rom J Intern Med; 2008; 46(4):351-5. PubMed ID: 19480302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
    Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
    Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A case report of osteomyelitis pubis in a hemodialysis patient with diabetes mellitus.
    Dovas S; Liakopoulos V; Simopoulou T; Giannopoulou M; Kanaki A; Anifandis G; Stefanidis I
    Ther Apher Dial; 2008 Oct; 12(5):409-12. PubMed ID: 18937727
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diffuse infiltrative lung disease associated with flecainide. Report of two cases.
    Pesenti S; Lauque D; Daste G; Boulay V; Pujazon MC; Carles P
    Respiration; 2002; 69(2):182-5. PubMed ID: 11961436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gender-associated differences in pharmacokinetics and anti-arrhythmic effects of flecainide in Japanese patients with supraventricular tachyarrhythmia.
    Doki K; Homma M; Kuga K; Aonuma K; Sakai S; Yamaguchi I; Kohda Y
    Eur J Clin Pharmacol; 2007 Oct; 63(10):951-7. PubMed ID: 17665182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A 42-year-old female with well-controlled atrial fibrillation and mild obstructive sleep apnea.
    Kapoor M; Greenough G
    J Clin Sleep Med; 2015 Mar; 11(3):274-6. PubMed ID: 25515285
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.